Phosphorylation of akt-1, which has been linked to chronic intestinal inflammation in IBD patients, suggests that baicalein’s protective effects might involve a more complex regulatory network, potentially modulating multiple signaling cascades (Zhang J. et al., 2022; Walldorf et al., 2021). Here, AKT1 is linked to inflammatory bowel disease.